Literature DB >> 5924390

[The effect of ildamen, a cardio-energetic coronary therapeutic agent, on cardiovascular dynamics].

N Sternitzke, J A Köhler, E Lang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5924390

Source DB:  PubMed          Journal:  Med Welt        ISSN： 0025-8512


× No keyword cloud information.
  6 in total

1.  Potentation of the cardiac response to aminophylline by oxyfedrine.

Authors:  K Sakai; G Pöch; W R Kukovetz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

2.  Effects of oxyfedrine and ouabain on the heart-lung preparation of the dog.

Authors:  K Sakai; S Sugano; C Isono
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

3.  Metabolism of oxyfedrine.

Authors:  K Sakai; S Sugano; I Watanabe; M Fukushima; S Takanashi; Y Nishii
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

4.  Cardioprotection by oxyfedrine in hereditary cardiomyopathic hamsters.

Authors:  K Lossnitzer; A Konrad; W Mohr; M Jakob; F Stroman
Journal:  Basic Res Cardiol       Date:  1979 Nov-Dec       Impact factor: 17.165

5.  A controlled comparison of oxyfedrine, isosorbide dinitrate and placebo in the treatment of patients suffering attacks of angina pectoris.

Authors:  J Whittington; E B Raftery
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

6.  Oxyfederine and propranolol--a controlled trial in angina pectoris.

Authors:  J Whittington; E B Raftery
Journal:  Br J Clin Pharmacol       Date:  1980-11       Impact factor: 4.335
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.